- Report
- July 2024
- 100 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- July 2024
- 100 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- July 2024
- 100 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- July 2024
- 100 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- July 2024
- 100 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- July 2024
- 100 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- July 2024
- 100 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- July 2024
- 100 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- July 2024
- 150 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- July 2024
- 150 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1391EUR$1,400USD£1,156GBP
€1987EUR$2,000USD£1,652GBP
- Report
- January 2024
- 150 Pages
Global
From €4818EUR$4,850USD£4,006GBP
- Report
- March 2024
- 150 Pages
Global
From €3609EUR$3,633USD£3,001GBP
€5156EUR$5,190USD£4,287GBP
- Report
- March 2024
- 150 Pages
Global
From €3609EUR$3,633USD£3,001GBP
€5156EUR$5,190USD£4,287GBP
- Report
- November 2023
- 149 Pages
Global
From €3164EUR$3,185USD£2,631GBP
€4520EUR$4,550USD£3,758GBP
- Report
- April 2024
- 145 Pages
Global
From €3924EUR$3,950USD£3,263GBP
- Report
- March 2024
- 126 Pages
Global
From €4222EUR$4,250USD£3,511GBP
- Report
- January 2024
- 147 Pages
Global
From €4222EUR$4,250USD£3,511GBP
- Report
- September 2024
- 150 Pages
Global
From €4818EUR$4,850USD£4,006GBP
- Report
- September 2024
- 150 Pages
Global
From €4818EUR$4,850USD£4,006GBP
The Cardiovascular Devices market is a segment of the medical device industry that focuses on the diagnosis, treatment, and prevention of cardiovascular diseases. It includes a range of products such as pacemakers, stents, catheters, and other implantable devices. These devices are used to diagnose and treat conditions such as arrhythmia, heart failure, and coronary artery disease.
The market is driven by factors such as the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive procedures. Additionally, the rising geriatric population and the increasing awareness of cardiovascular diseases are expected to drive the market growth.
Some of the major companies in the Cardiovascular Devices market include Medtronic, Abbott Laboratories, Boston Scientific Corporation, St. Jude Medical, and Johnson & Johnson. Show Less Read more